Melanoma Journal Articles September 2019
Dove Press
A new strategy for accurate targeted diagnosis and treatment of cutaneous malignant melanoma: dual-mode phase-change lipid nanodroplets as ultrasound contrast agents
Authors Yang H, Cai W, Lv W, Zhao P, Shen Y, Zhang L, Ma B, Yuan L, Duan Y, Yao K
Received 3 March 2019
Accepted for publication 1 July 2019
Published 2 September 2019 Volume 2019:14 Pages 7079—7093
DOI https://doi.org/10.2147/IJN.S207419
Cancer Letters
Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment
RamounaVoshtania MeiSongb HuanWanga XiaoqiLia WeiZhangc Mojdeh S.Tavallaied WenjunYana JosephSune FangWeia XiaojingMaab
https://doi.org/10.1016/j.canlet.2019.08.018
Future Medicine
Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma
Kristy K Broman & Jonathan S Zager
Published Online: 2 Sep 2019 https://doi.org/10.2217/mmt-2019-0006
Cancer Immunology Research
STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity
Rana Falahat, Patricio Perez-Villarroel, Adam W Mailloux, Genyuan Zhu, Shari Pilon-Thomas, Glen N Barber and James J Mulé
DOI: 10.1158/2326-6066.CIR-19-0229
BioRxiv
Targeting effector pathways in RAC1P29S-driven malignant melanoma
Cristina Uribe-Alvarez, Sandra Lucía Guerrero-Rodríguez, Jennifer Rhodes, Alexa Cannon, View ORCID ProfileJonathan Chernoff, Daniela Araiza-Olivera
doi: https://doi.org/10.1101/750489
JAMA Dermatology
Evolution of Excisional Surgery Practices for Melanoma in the United States
Michael P. Lee, BS1; Joseph F. Sobanko, MD2; Thuzar M. Shin, MD, PhD2; et al
JAMA Dermatol. Published online August 28, 2019. doi:10.1001/jamadermatol.2019.2346
Journal of Extracellular Vesicles
Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma
Su Chul Jang,Rossella Crescitelli,Aleksander Cvjetkovic,Valerio Belgrano,Roger Olofsson Bagge,Karin Sundfeldt, show all
Article: 1635420 | Received 12 May 2018, Accepted 14 Jun 2019, Published online: 27 Aug 2019
British Medical Journal
Diffuse melanosis cutis
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4901 (Published 05 September 2019)Cite this as: BMJ 2019;366:l4901
Antibiotocs
Article Tobramycin Promotes Melanogenesis by Upregulating p38 MAPK Protein Phosphorylation in B16F10 Melanoma Cells
Seung-Hyun Moon, You Chul Chung and Chang-Gu Hyun *
Department of Chemistry and Cosmetics, Jeju National University, Jeju 63243, Korea *
Received: 26 July 2019; Accepted: 2 September 2019; Published: 5 September 2019
Antibiotics 2019, 8, 140; doi:10.3390/antibiotics8030140
Current Oncology
Practice Guideline
Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline
F.C. Wright, MEd MD*, L.H. Souter, PhD†, S. Kellett, MEnvSc†, A. Easson, MD MSc‡, C. Murray, MD§, J. Toye, MD||, D. McCready, MD MSc‡, C. Nessim, MD#, D. Ghazarian, MD**, N.J. Look Hong, MD MSc††, S. Johnson, MD#, D.P. Goldstein, MD**, T. Petrella, MD*, the Melanoma Disease Site Group
doi: http://dx.doi.org/10.3747/co.26.4885
JAAD
Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring
Aimilios Lallas, PhD1, , Zoe Apalla, PhD2, Athanassios Kyrgidis, PhD3, Chryssoula Papageorgiou, MD1, Ioannis Boukovinas, MD4, Mattheos Bobos, PhD5, George Efthimiopoulos, MD6, Christina Nikolaidou, MD7, Andreas Moutsoudis, MD1, Theodosia Gkentsidi, MD1, Konstantinos Lallas, MD1, Elizabeth Lazaridou, PhD8, Elena Sotiriou, PhD1, Efstratios Vakirlis, PhD1, Dimitrios Ioannides, PhD1
DOI: https://doi.org/10.1016/j.jaad.2019.08.074
Journal of Experimental and Clinical Cancer Research
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
- Alexander Thiem,
- Sonja Hesbacher,
- Hermann Kneitz,
- Teresa di Primio,
- Markus V. Heppt,
- Heike M. Hermanns,
- Matthias Goebeler,
- Svenja Meierjohann,
- Roland Houben&
- David Schrama
Journal of Experimental & Clinical Cancer Research volume 38, Article number: 397 (2019) https://doi.org/10.1186/s13046-019-1403-9
Cancers
Review Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside
Taku Fujimura 1,* , Yasuhiro Fujisawa 2 , Yumi Kambayashi 1 and Setsuya Aiba 1
Received: 29 August 2019; Accepted: 9 September 2019; Published: 11 September 2019
Clinical Cancer Research
High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling
Maria I. Toki, Christopher R. Merritt, Pok Fai Wong, James W. Smithy, Harriet M. Kluger, Konstantinos N. Syrigos, Giang T. Ong, Sarah E. Warren, Joseph M. Beechem and David L. Rimm
DOI: 10.1158/1078-0432.CCR-19-0104 Published September 2019
Molecular Cancer Therapeutics
Research Article
Utility of the RIG-I agonist triphosphate RNA for melanoma therapy
Mike W Helms, Kerstin Jahn-Hofmann, Felix Gnerlich, Christiane Metz-Weidmann, Monika Braun, Gabriele Dietert, Petra Scherer, Kaj Grandien, Joachim Theilhaber, Hui Cao, Timothy R. Wagenaar, Max M. Schnurr, Stefan Endres, Dmitri Wiederschain, Sabine Scheidler, Simon Rothenfußer, Bodo Brunner and Lars M. König
DOI: 10.1158/1535-7163.MCT-18-1262
Published Online First September 12, 2019
Food and Beverage Consumption and Melanoma Risk: A Population-Based Case-Control Study in Northern Italy
by Carlotta Malagoli 1,Marcella Malavolti 1,Francesca Farnetani 2,Caterina Longo 2,Tommaso Filippini 1,Giovanni Pellacani 2 andMarco Vinceti 1,3,*
Nutrients 2019, 11(9), 2206; https://doi.org/10.3390/nu11092206
Received: 19 July 2019 / Revised: 9 September 2019 / Accepted: 10 September 2019 / Published: 12 September 2019
British Journal of Dermatology
A risk prediction model for development of subsequent primary melanoma in a population?based cohort
A.E. Cust C. Badcock J Smith N.E. Thomas L.E. Haydu B.K. Armstrong M.H. Law J.F. Thompson P.A. Kanetsky C.B. Begg Y. Shi A. Kricker I. Orlow A. Sharma S. Yoo S.F. Leong …
First published: 14 September 2019
https://doi.org/10.1111/bjd.18524
Molecular Cancer Therapeutics
Distinct transcriptional programming drive response to MAPK inhibition in BRAFV600 mutant melanoma patient derived xenografts
Tianshu Feng, Javad Golji, Ailing Li, Xiamei Zhang, David A. Ruddy, Daniel P Rakiec, Felipe C. Geyer, Jane Gu, Hui Gao, Juliet A Williams, Darrin D. Stuart and Matthew J Meyer
DOI: 10.1158/1535-7163.MCT-19-0028
A meta?analysis on the influence of partial biopsy of primary melanoma on disease recurrence and patient survival
First published: 23 August 2019
https://doi.org/10.1111/jdv.15903
Journal of Pineal Research
ORIGINAL ARTICLE
Full Access
Melatonin exerts oncostatic capacity and decreases melanogenesis in human MNT?1 melanoma cells
Konrad Kleszczy?ski Tae?Kang Kim Bernadetta Bilska Michal Sarna Krystian Mokrzynski Agatha Stegemann El?bieta Pyza Russel J. Reiter Kerstin Steinbrink Markus Böhm Andrzej T. Slominski
First published: 18 September 2019
https://doi.org/10.1111/jpi.12610
British Journal of Dermatology
The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population?based matched cohort study in Korea
H.S. Kim H.J. Kim E.S. Hong K.B. Kim J.D. Lee T.U. Kang H.S. Ahn
First published: 24 June 2019
https://doi.org/10.1111/bjd.18247
JMRI
Susceptibility?weighted imaging in malignant melanoma brain metastasis
Daniel Schwarz MD Thomas Niederle Philipp Münch Thomas Hielscher MSc Jessica C. Hassel MD Heinz?Peter Schlemmer MD Michael Platten MD Frank Winkler MD … See all authors
First published: 21 February 2019
https://doi.org/10.1002/jmri.26692
Cancer Immunology Research
STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity
Rana Falahat, Patricio Perez-Villarroel, Adam W. Mailloux, Genyuan Zhu, Shari Pilon-Thomas, Glen N. Barber and James J. Mulé
DOI: 10.1158/2326-6066.CIR-19-0229
Pigment Cell & Melanoma
A genome?wide CRISPR screen identifies FBXO42 involvement in resistance towards MEK inhibition in NRAS mutant melanoma
Adi Nagler David W. Vredevoogd Michal Alon Phil F. Cheng Sophie Trabish Shelly Kalaora Rand Arafeh Victoria Goldin Mitchell P. Levesque Daniel S. Peeper Yardena Samuels
First published: 24 September 2019
https://doi.org/10.1111/pcmr.12825
British Journal of Dermatology
Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines
- VuongB.K. ArmstrongM. Drummond J.L. Hopper J.H. Barrett J.R. Davies D.T. Bishop J. Newton?Bishop J.F. Aitken G.G. Giles H. Schmid M.A. Jenkins G.J. Mann K. McGeechan A.E. Cust
First published: 04 August 2019 https://doi.org/10.1111/bjd.18411
Ears, Nose and Throat Journal
Sex- and Site-Related Significance in Cutaneous Head and Neck Melanoma
Andro Košec, MD, PhD, FEBORL-HNS, Ivan Raši?, MD, PhD, Alan Pegan, MD, PhD, …
https://doi.org/10.1177/0145561319875949
First Published September 23, 2019
Translational Cancer Research
MicroRNA-204-3p modulates epithelial-mesenchymal transition by targeting paired box gene 2 in human melanoma A-375 cells
Authors: Jun Song, Xinyan Chen, Liping Zhang, Dandan Song, Huizi Xiong
New England Journal of Medicine
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- James Larkin, F.R.C.P., Ph.D.,
- Vanna Chiarion-Sileni, M.D.,
- Rene Gonzalez, M.D.,
- Jean-Jacques Grob, M.D.,
- Piotr Rutkowski, M.D., Ph.D.,
- Christopher D. Lao, M.D.,
- Lance Cowey, M.D., M.P.H.,
- Dirk Schadendorf, M.D.,
- John Wagstaff, M.D.,
- Reinhard Dummer, M.D.,
- Pier F. Ferrucci, M.D.,
- Michael Smylie, M.D.,
Et al.
September 28, 2019
DOI: 10.1056/NEJMoa1910836
British Journal of Dermatology
Clinicopathological factors associated with death from thin (?1.00mm) melanoma
First published: 28 September 2019
https://doi.org/10.1111/bjd.18560
Chemico-Biological Interactions
Available online 30 September 2019, 108822
Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes
Author links open overlay panelJenny MaeSamsona1Dinoop RavindranMenona1Derek E.Smithb1ErikaBairdaTakayukiKitanoacDexiangGaobAik-ChoonTandMayumiFujitaaef
https://doi.org/10.1016/j.cbi.2019.108822
Journal of Investigative Dermatology
Available online 30 September 2019
MicroRNA Ratios Distinguish Melanomas from Nevi
Author links open overlay panelRodrigoTorres1Ursula E.Lang12MiroslavHejna34Samuel J.Shelton5Nancy M.Joseph2A. HunterShain1IweiYeh12Maria L.Wei16Michael C.Oldham5Boris C.Bastian12Robert L.Judson-Torres178
Show more
https://doi.org/10.1016/j.jid.2019.06.126
Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland
Edoardo Botteri, Nathalie C. Støer, Elisabete Weiderpass, Eero Pukkala, Olavi Ylikorkala and Heli Lyytinen
DOI: 10.1158/1055-9965.EPI-19-0554
Published Online First September 30, 2019
doi: 10.1158/1055-9965.EPI-19-0554
EBio Medicine
Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
Inna Smalleya , Eunjung Kimb , Jiannong Lic , Paige Spencea , Clayton J. Wyatta , Zeynep Eroglud, Vernon K. Sondakd, Jane L. Messinad,e , Nalan Akgul Babacand, Silvya Stuchi Maria-Englerf , Lesley De Armasg , Sion L. Williamsg , Robert A. Gatenbyc , Y. Ann Chenc,? , Alexander R.A. Andersonb,? , Keiran S.M. Smalleya,d,??
Received 21 June 2019 Revised 13 September 2019 Accepted 13 September 2019
https://doi.org/10.1016/j.ebiom.2019.09.023